Tango Therapeutics TNGX Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's short-term investments?
- Tango Therapeutics (TNGX) reported short-term investments of $222.01M in Q1 2026.
- How has Tango Therapeutics's short-term investments changed year-over-year?
- Tango Therapeutics's short-term investments increased by 40.3% year-over-year, from $158.29M to $222.01M.
- What is the long-term trend for Tango Therapeutics's short-term investments?
- Over 5 years (2020 to 2025), Tango Therapeutics's short-term investments has grown at a 7.3% compound annual growth rate (CAGR), from $161.94M to $230.86M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.